By Mary Ann Liebert, Inc., publishers
A study of more than 5,400 instructors and assistant professors at Harvard Medical School compared differences between males and females for receipt of their first National Institutes of Health research award.
By TSRL, Inc
TSRL, Inc. was awarded up to $3.6 million in grant funding from the National Institute of Allergy & Infectious Diseases to develop novel antibacterials for difficult-to-treat skin and soft tissue infections.
By Oakland University
Oakland University Professor Yang Xia, Ph.D., is now studying how to monitor what happens to the body before the disease sets in.
New Funding and Renewed Hope for ME/CFS Patients in the United States
By ARDS Foundation
Eileen Rubin, President of the ARDS Foundation in Northbrook IL, speaks at educational briefing on ARDS and Sepsis for congressional staff on Capitol Hill
By Beacon Biomedical
Beacon Biomedical, Inc., a privately held company focused on developing patient friendly cancer screening tests was awarded a Phase I Small Business Innovation Research (SBIR) Phase I Grant by the National Institutes of Health
By Cure SMA
The SMA drug pipeline has grown dramatically in just over a decade. Of the 17 programs in the pipeline, seven of these are in clinical trials, and two of those are in Phase 3 clinical trials.